Transphorm Inc

TGAN RSI Chart

TGAN Valuation

Market Cap

182.2M

Price/Earnings (Trailing)

-5.39

Price/Sales (Trailing)

9.81

Price/Free Cashflow

-11.75

TGAN Price/Sales (Trailing)

TGAN Profitability

Operating Margin

4.13%

Return on Equity

-142.79%

Return on Assets

-98.66%

Free Cashflow Yield

-8.51%

TGAN Fundamentals

TGAN Revenue

Revenue (TTM)

18.6M

Revenue Y/Y

36.51%

Revenue Q/Q

-14.84%

TGAN Earnings

Earnings (TTM)

-33.8M

Earnings Y/Y

-18.92%

Earnings Q/Q

4.27%

Price Action

Last 7 days

-3.3%

Last 30 days

10.1%

TGAN Financial Health

Current Ratio

2.63

TGAN Investor Care

Shares Dilution (1Y)

9.46%

Diluted EPS (TTM)

-0.68

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	16.5M	17.2M	18.6M	0
2022	24.1M	26.0M	18.4M	18.2M
2021	12.7M	9.6M	19.0M	21.5M
2020	12.5M	18.3M	19.3M	11.3M
2019	4.0M	6.7M	9.3M	11.9M
2018	0	0	0	1.4M

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for TGAN

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 22, 2023	smales kelly	sold	-10,498	2.628	-3,995	-
Nov 22, 2023	mcfarland katharina g.	sold	-10,798	2.703	-3,995	-
Nov 20, 2023	smales kelly	sold	-1,894	2.888	-656	-
Nov 20, 2023	mcfarland katharina g.	sold	-10,580	3.01	-3,515	-
Nov 17, 2023	parikh primit	sold (taxes)	-22,351	2.77	-8,069	president and ceo
Nov 17, 2023	smales kelly	sold	-9,093	2.818	-3,227	-
Nov 17, 2023	mcaulay cameron	sold (taxes)	-7,024	2.77	-2,536	chief financial officer
Nov 17, 2023	mishra umesh	sold (taxes)	-4,470	2.77	-1,614	chief technology officer
Oct 20, 2023	moreland cynthia j	acquired	-	-	2,083	-
Oct 20, 2023	smales kelly	acquired	-	-	2,708	-

Which funds bought or sold TGAN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Dec 06, 2023	CITIGROUP INC	reduced	-99.84	-27,338	29.00	-%
Nov 24, 2023	DEUTSCHE BANK AG\	reduced	-95.81	-61,573	1,732	-%
Nov 21, 2023	Alpine Global Management, LLC	sold off	-100	-250,580	-	-%
Nov 15, 2023	MORGAN STANLEY	added	35.08	-9,137	68,321	-%
Nov 15, 2023	Worth Venture Partners, LLC	added	4.59	-1,187,660	2,558,060	1.52%
Nov 14, 2023	Kohlberg Kravis Roberts & Co. L.P.	unchanged	-	-26,757,700	50,340,700	1.77%
Nov 14, 2023	SOROS FUND MANAGEMENT LLC	reduced	-20.93	-707,200	754,800	0.01%
Nov 14, 2023	JPMORGAN CHASE & CO	reduced	-85.64	-376,039	38,901	-%
Nov 14, 2023	Royal Bank of Canada	added	109	2,000	8,000	-%
Nov 14, 2023	VANGUARD GROUP INC	added	6.86	-1,408,730	3,251,950	-%

Latest Funds Activity

Are funds buying TGAN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own TGAN

No. of Funds

Recent SEC filings of Transphorm Inc

View All Filings

Date Filed	Form Type	Document
Nov 27, 2023	144/A	144/A
Nov 27, 2023	144/A	144/A
Nov 27, 2023	144/A	144/A
Nov 27, 2023	144/A	144/A
Nov 27, 2023	144/A	144/A
Nov 27, 2023	4	Insider Trading
Nov 27, 2023	4	Insider Trading
Nov 21, 2023	4	Insider Trading
Nov 21, 2023	4	Insider Trading
Nov 21, 2023	4	Insider Trading

Peers (Alternatives to Transphorm Inc)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
NVDA	1.2T	44.9B	2.01%	176.71%	62.2	26.18	57.07%	217.10%
AMD	208.2B	22.1B	13.51%	82.97%	1.0K	9.42	-3.14%	-90.85%
INTC	180.0B	52.9B	12.61%	51.97%	-109.5	3.41	-23.98%	-112.36%
AMAT	123.8B	26.5B	2.42%	36.33%	19.21	4.66	5.50%	-3.05%
ADI	91.7B	12.3B	9.45%	9.48%	27.68	7.46	2.43%	20.59%
MID-CAP
AMKR	7.1B	6.7B	23.06%	6.76%	17.39	1.06	-3.65%	-50.30%
CRUS	4.3B	1.8B	9.02%	1.07%	30.6	2.45	-10.70%	-59.88%
ACLS	4.0B	1.1B	-5.85%	49.75%	17.32	3.7	26.38%	43.48%
DIOD	3.3B	1.8B	7.92%	-18.08%	11.26	1.8	-7.52%	-3.55%
AMBA	2.3B	290.7M	16.64%	-27.14%	-23.52	7.93	-17.79%	-146.17%
SMALL-CAP
ACMR	958.4M	495.9M	-9.50%	77.78%	13.41	1.93	32.10%	66.11%
AEHR	744.7M	74.9M	9.06%	1.17%	39.95	9.94	34.12%	99.53%
AOSL	630.4M	663.5M	7.12%	-29.81%	-79.92	0.95	-16.96%	-101.73%
ATOM	181.5M	-	33.84%	-2.49%	-9.32	576.4	-4.50%	-12.39%
ASYS	92.2M	117.9M	-5.48%	-25.65%	25.5	0.78	19.93%	-73.89%

Transphorm Inc News

Latest updates

Marketscreener.com • 30 Nov 2023 • 01:32 pm • 9 days ago

Transphorm Releases Two Battery Charger Reference Designs ...

Stockhouse Publishing • 09 Nov 2023 • 08:00 am • 30 days ago

2023-11-09 | NDAQ:TGAN | Press Release | Transphorm ...

Yahoo Finance • 08 Nov 2023 • 08:00 am • 31 days ago

Transphorm, Inc.'s (NASDAQ:TGAN) largest shareholders are ...

Business Wire India • 07 Nov 2023 • 08:00 am • 32 days ago

Newmont Acquires Newcrest Successfully Creating Worlds Leading ...

Yahoo Finance • 25 Oct 2023 • 07:00 am • 45 days ago

Impinj (PI) Reports Break-Even Earnings for Q3

Insider Monkey • 03 Oct 2023 • 07:00 am • 2 months ago

5 George Soros Stocks that are on Sale Now

Yahoo Finance • 24 Aug 2023 • 07:00 am • 3 months ago

Transphorm's GaN Powers World's First Integrated Microinverter PV ...

Barchart • 14 Aug 2023 • 07:00 am • 3 months ago

Markets Today: Stocks Fall on Negative Carryover from China's Debt ...

Seeking Alpha • 11 Aug 2023 • 07:00 am • 4 months ago

Benchmark ups Rigetti Computing to buy after "solid results ...

Yahoo Finance • 09 Aug 2023 • 07:00 am • 4 months ago

Transphorm's GaN First to Hit Short Circuit Robustness Milestone ...

Yahoo Finance • 06 Jul 2023 • 07:00 am • 5 months ago

Transphorm Confirms Gallium Nitride Materials Sources Are Secure

Yahoo Finance • 29 May 2023 • 07:00 am • 6 months ago

Ambarella (AMBA) Stock Jumps 8.3%: Will It Continue to Soar?

Simply Wall St • 17 May 2023 • 07:00 am • 6 months ago

Revenues Tell The Story For Transphorm, Inc. (NASDAQ:TGAN)

Yahoo Finance • 02 May 2023 • 07:00 am • 7 months ago

Advanced Micro Devices (AMD) Q1 Earnings and Revenues Beat ...

Seeking Alpha • 28 Jul 2022 • 07:00 am • 16 months ago

Transphorm (TGAN): Turning Technology Into Revenue, A ...

Financials for Transphorm Inc

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																				(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-14.8%	5,010,000	5,883,000	3,192,000	4,493,000	3,670,000	5,156,000	4,927,000	4,604,000	11,303,000	3,216,000	2,425,000	2,013,000	1,929,000	6,300,000	1,100,000	9,928,500	994,000	488,000	529,000	-
Cost Of Revenue	1.1%	3,836,000	3,795,000	3,017,000	7,162,000	3,232,000	4,050,000	3,789,000	3,935,000	2,239,000	2,567,000	1,788,000	1,936,000	2,043,000	1,248,000	1,455,000	2,281,000	1,625,000	1,182,000	1,404,000	-
Gross Profit	-43.8%	1,174,000	2,088,000	175,000	-2,669,000	438,000	1,106,000	1,138,000	669,000	9,064,000	649,000	637,000	-	-	-	-	-	-	-	-	-
Costs and Expenses	-13.5%	7,672,000	8,867,000	8,518,000	7,229,000	5,940,000	6,140,000	5,596,000	5,437,000	5,130,000	5,253,000	5,176,000	6,460,000	6,349,000	5,428,000	6,531,000	7,284,000	5,508,000	5,373,000	5,688,000	-
S&GA Expenses	15.2%	1,708,000	1,482,000	1,651,000	1,447,000	1,066,000	1,083,000	1,047,000	976,000	825,000	687,000	663,000	581,000	547,000	528,000	518,000	511,000	572,000	675,000	851,000	10,337
R&D Expenses	5.3%	3,022,000	2,869,000	3,013,000	2,325,000	1,830,000	1,740,000	1,632,000	1,609,000	1,591,000	1,823,000	1,780,000	1,453,000	1,071,000	1,594,000	1,466,000	1,901,000	2,041,000	2,022,000	2,182,000	-
Interest Expenses	-100.0%	-	8,000	180,000	184,000	184,000	182,000	181,000	187,000	220,000	204,000	187,000	191,000	191,000	189,000	189,000	191,000	191,000	189,000	187,000	969
Income Taxes	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	4.3%	-7,129,000	-7,447,000	-8,792,000	-10,460,000	-5,995,000	-5,353,000	-4,999,000	-4,164,000	5,980,000	-7,052,000	-6,579,000	-4,712,000	-6,740,000	-2,270,000	-4,187,000	2,434,000	-5,446,000	-5,901,000	-6,370,000	-11,306
Net Income Margin	4.0%	-1.82	-1.90	-1.85	-1.47	-1.12	-0.33	-0.43	-0.55	-0.65	-2.62	-1.60	-1.58	-0.40	-0.35	-0.81	-1.03	-6.61	-6.04	-3.02	-0.03
Free Cashflow	46.5%	-4,697,000	-8,773,000	-9,230,000	7,193,000	-8,190,000	-5,636,000	-5,731,000	-5,579,000	-3,892,000	-5,129,000	-5,097,000	-1,434,000	-3,205,000	-3,383,000	-6,151,000	-62,285	-40,389	-1,173,000	-5,434,000	-98,900

Balance Sheet
(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	1.7%	34,289	33,715	44,452	49,245	57,950	63,730	48,646	54,842	14,336	14,034	18,144	22,226	12,866	17,743	23,152	10,262	10,321	10,381	10,440	10,499	7,001
Current Assets	8.0%	21,925	20,295	30,688	36,399	46,647	55,854	44,794	50,661	10,176	9,793	14,294	18,226	8,609	13,321	18,557	5,357	1.00	2.00	3.00	4,825	4.00
Cash Equivalents	85.8%	6,152	3,311	15,527	23,149	33,496	42,613	33,435	40,467	1,988	2,462	9,500	14,694	4,369	9,382	14,648	2,875	2,911	4,398	2,507	3,069	4.00
Inventory	10.0%	9,776	8,885	8,406	7,476	8,966	6,963	6,330	5,956	4,774	2,924	2,223	1,627	1,372	1,342	1,085	990	-	-	-	852	-
Net PPE	-1.3%	7,857	7,957	7,890	5,367	5,328	2,199	1,649	1,897	1,761	1,832	1,360	1,324	1,432	1,533	1,637	1,770	-	-	-	2,132	-
Goodwill	-3.1%	963	994	1,079	1,097	996	1,056	1,180	1,250	1,286	1,303	1,302	1,397	1,362	1,336	1,326	1,325	-	-	-	1,306	-
Liabilities	-2.7%	10,598	10,891	24,837	21,063	21,605	21,792	17,285	18,623	33,882	45,037	43,199	42,082	42,354	41,095	44,321	46,857	43,238	39,619	35,999	32,380	21,604
Current Liabilities	0.8%	8,339	8,271	21,937	18,393	18,802	18,851	5,285	6,623	21,882	15,847	27,071	26,690	26,027	25,515	30,436	20,688	117	108	95.00	16,528	71.00
Shareholder's Equity	3.8%	23,691	22,824	19,615	28,182	36,345	41,938	31,361	36,219	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-3.2%	-229,424	-222,295	-209,236	-200,446	-189,986	-183,991	-178,638	-173,639	-169,475	-175,455	-168,403	-161,824	-157,112	-150,372	-148,102	-143,915	-140	-130	-117	-128,632	-91.48
Additional Paid-In Capital	3.3%	255,249	247,027	230,272	229,954	228,178	227,512	211,190	210,841	150,843	145,332	144,201	142,736	128,385	127,787	127,683	22,404	25.00	25.00	25.00	21,829	25.00
Shares Outstanding	4.4%	61,981	59,374	57,047	56,862	56,626	54,405	53,379	49,148	41,196	40,637	40,532	35,720	35,157	35,136	31,912	4,221	28,154	28,154	28,154	4,220	2,308

Cashflow (Last 12 Months)
(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	53.2%	-4,107	-8,773	-7,927	8,800	-4,887	-4,913	-5,826	-5,298	-3,829	-4,783	-4,933	-1,422	-3,181	-3,361	-6,151	-490	-1.39	-565	-5,351	-15.90	-45*
Share Based Compensation	-54.4%	913	2,003	857	1,123	636	583	758	848	511	497	513	705	584	104	132	131	159	137	139	-	-
Cashflow From Investing	22.3%	-590	-759	-2,054	-2,639	-4,052	-1,401	-666	-965	-1,126	-2,364	-1,132	-2,033	-1,924	-1,901	-1,548	-1,050	-632	-1,030	-189	-	-
Cashflow From Financing	367.6%	7,654	-2,860	2,411	653	30.00	15,740	-409	44,773	5,000	134	956	13,646	14.00	-	19,498	2,000	4,000	2,008	5,000	-	-

TGAN Income Statement

2023-09-30

Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue, net, including related parties (Note 11)	$ 5,010	$ 3,670	$ 10,893	$ 8,826
Cost of goods sold	3,836	3,232	7,631	7,282
Gross profit	1,174	438	3,262	1,544
Operating expenses:
Research and development	3,022	1,830	5,891	3,570
Sales and marketing	1,708	1,066	3,190	2,149
General and administrative	2,942	3,044	7,458	6,361
Total operating expenses	7,672	5,940	16,539	12,080
Loss from operations	(6,498)	(5,502)	(13,277)	(10,536)
Interest expense	0	184	8	366
Loss in joint venture	721	684	1,581	1,266
Other income, net	(90)	(375)	(290)	(820)
Loss before tax expense	(7,129)	(5,995)	(14,576)	(11,348)
Tax expense	0	0	0	0
Net loss	(7,129)	(5,995)	(14,576)	(11,348)
Deemed dividend related to warrant modification and issuance of Inducement Warrants (Note 8)	0	0	5,612	0
Net loss attributable to common stockholders	(7,129)	(5,995)	(20,188)	(11,348)
Net loss attributable to common stockholders	$ (7,129)	$ (5,995)	$ (20,188)	$ (11,348)
Net loss per share - basic (in usd per share)	$ (0.12)	$ (0.10)	$ (0.33)	$ (0.20)
Net loss per share - diluted (in usd per share)	$ (0.12)	$ (0.10)	$ (0.33)	$ (0.20)
Weighted average common shares outstanding - basic (in shares)	61,138,691	56,619,662	61,071,729	55,518,297
Weighted average common shares outstanding - diluted (in shares)	61,138,691	56,619,662	61,071,729	55,518,297

TGAN Balance Sheet

2023-09-30

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 6,152	$ 15,527
Restricted cash	0	500
Accounts receivable, net of allowance for doubtful accounts of $263 and $0 at September 30, 2023 and March 31, 2023, respectively, including related parties (Note 11)	4,571	4,396
Inventory	9,776	8,406
Prepaid expenses and other current assets	1,426	1,859
Total current assets	21,925	30,688
Property and equipment, net	7,857	7,890
Operating lease right-of-use assets	2,719	3,033
Goodwill	963	1,079
Intangible assets, net	173	321
Investment in joint venture	0	715
Other assets	652	726
Total assets	34,289	44,452
Current liabilities:
Accounts payable and accrued expenses, including related parties (Note 11)	6,198	7,895
Accrued interest	0	180
Unfunded commitment in joint venture	59	0
Accrued payroll and benefits	1,557	1,458
Operating lease liabilities	525	404
Revolving credit facility	0	12,000
Total current liabilities	8,339	21,937
Operating lease liabilities, net of current portion	2,259	2,670
Other liabilities	0	230
Total liabilities	10,598	24,837
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized and none issued and outstanding as of September 30, 2023 and March 31, 2023	0	0
Common stock, $0.0001 par value; 750,000,000 shares authorized as of September 30, 2023 and March 31, 2023, and 61,981,134 and 57,047,013 shares issued and outstanding as of September 30, 2023 and March 31, 2023, respectively	6	6
Additional paid-in capital	255,249	230,272
Accumulated deficit	(229,424)	(209,236)
Accumulated other comprehensive loss	(2,140)	(1,427)
Total stockholders’ equity	23,691	19,615
Total liabilities and stockholders’ equity	$ 34,289	$ 44,452

About Transphorm Inc

Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications. The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.

CEO	Dr. Primit A. Parikh Ph.D.
WEBSITE	www.transphormusa.com
EMPLOYEES	131

Transphorm Inc Frequently Asked Questions

What is the ticker symbol for Transphorm Inc? What does TGAN stand for in stocks?

TGAN is the stock ticker symbol of Transphorm Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Transphorm Inc (TGAN)?

As of Fri Dec 08 2023, market cap of Transphorm Inc is 182.22 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TGAN stock?

You can check TGAN's fair value in chart. The fair value of Transphorm Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Transphorm Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TGAN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Transphorm Inc a good stock to buy?

The fair value guage provides a quick view whether TGAN is over valued or under valued. Whether Transphorm Inc is cheap or expensive depends on the assumptions which impact Transphorm Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TGAN.

What is Transphorm Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 08 2023, TGAN's PE ratio (Price to Earnings) is -5.39 and Price to Sales (PS) ratio is 9.81. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TGAN PE ratio will change depending on the future growth rate expectations of investors.

TGAN RSI Chart

TGAN Valuation

TGAN Price/Sales (Trailing)

TGAN Profitability

TGAN Fundamentals

TGAN Revenue

TGAN Earnings

Price Action

TGAN Financial Health

TGAN Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for TGAN

Which funds bought or sold TGAN recently?

Latest Funds Activity

Recent SEC filings of Transphorm Inc

Peers (Alternatives to Transphorm Inc)

Transphorm Inc News

Financials for Transphorm Inc

Income Statement (Last 12 Months)

Balance Sheet.css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Thousands)

Cashflow (Last 12 Months)(In Thousands)

TGAN Income Statement

TGAN Balance Sheet

About Transphorm Inc

Transphorm Inc Frequently Asked Questions

What is the ticker symbol for Transphorm Inc? What does TGAN stand for in stocks?

What is the market capital of Transphorm Inc (TGAN)?

What is the fair value of TGAN stock?

Is Transphorm Inc a good stock to buy?

What is Transphorm Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

Balance Sheet
(In Thousands)

Cashflow (Last 12 Months)
(In Thousands)